LEADER 01278nam  2200361 a 450 
001 9910697088803321
005 20230902161730.0
035   $a(CKB)5470000002384010
035   $a(OCoLC)589331429
035   $a(EXLCZ)995470000002384010
100   $a20100331d2009      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aDrug safety$b[electronic resource] $eFDA has begun efforts to enhance postmarket safety, but additional actions are needed : report to the Ranking Member, Committee on Finance, U.S. Senate
210  1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2009]
215   $a1 online resource (ii, 48 pages) $cillustrations
300   $aTitle from PDF title screen (GAO, viewed Mar. 10, 2010).
300   $a"November 2009."
300   $a"GAO-10-68."
320   $aIncludes bibliographical references.
517   $aDrug safety 
606   $aDrugs$zUnited States$xSafety measures
615  0$aDrugs$xSafety measures.
712 02$aUnited States.$bCongress.$bSenate.$bCommittee on Finance.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910697088803321
996   $aDrug safety$92379886
997   $aUNINA